The Role of Hydrogen Sulfide in the Localization and Expression of p53 and Cell Death in the Nervous Tissue in Traumatic Brain Injury and Axotomy

Int J Mol Sci. 2023 Oct 28;24(21):15708. doi: 10.3390/ijms242115708.

Abstract

Traumatic brain injury (TBI) is one of the leading causes of disability and death worldwide. It is characterized by various molecular-cellular events, with the main ones being apoptosis and damage to axons. To date, there are no clinically effective neuroprotective drugs. In this study, we examined the role of hydrogen sulfide (H2S) in the localization and expression of the key pro-apoptotic protein p53, as well as cell death in the nervous tissue in TBI and axotomy. We used a fast donor (sodium sulphide, Na2S) H2S and a classic inhibitor (aminooxyacetic acid, AOAA) of cystathionine β-synthase (CBS), which is a key enzyme in H2S synthesis. These studies were carried out on three models of neurotrauma in vertebrates and invertebrates. As a result, it was found that Na2S exhibits a pronounced neuroprotective effect that reduces the number of TUNEL-positive neurons and glial cells in TBI and apoptotic glia in axotomy. This effect could be realized through the Na2S-dependent decrease in the level of p53 in the cells of the nervous tissue of vertebrates and invertebrates, which we observed in our study. We also observed the opposite effect when using AOAA, which indicates the important role of CBS in the regulation of p53 expression and death of neurons and glial cells in TBI and axotomy.

Keywords: apoptosis; axotomy; glial cells; hydrogen sulfide; necrosis; neuron; p53; traumatic brain injury.

MeSH terms

  • Animals
  • Apoptosis
  • Axotomy
  • Brain Injuries, Traumatic*
  • Cystathionine beta-Synthase / metabolism
  • Hydrogen Sulfide* / metabolism
  • Hydrogen Sulfide* / pharmacology
  • Nerve Tissue* / metabolism
  • Neuroprotective Agents* / pharmacology
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Hydrogen Sulfide
  • Tumor Suppressor Protein p53
  • Neuroprotective Agents
  • Cystathionine beta-Synthase

Grants and funding